Companies: 10,795·Total market cap: $144.5T
Revolution Medicines, Inc.

Revolution Medicines, Inc.

RVMDNASDAQHealthcare● Active
$148.30
$-0.93(-0.63%)
Market Cap$31.5B
P/E Ratio
52W High$166.5
52W Low$34

Revolution Medicines, Inc.(RVMD)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · RVMD · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.01B$0.04B$0.03B
Cost of Revenue$0.02B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.02B)$0.00B$0.01B$0.04B$0.03B
Gross Margin %(computed)100.00%100.00%100.00%
Operating Expenses
R&D Expenses$0.98B$0.59B$0.42B$0.25B$0.19B
G&A Expenses$0.19B$0.10B$0.08B$0.04B$0.03B
Total Operating Expenses$1.17B$0.69B$0.50B$0.29B$0.22B
Operating Income($1.18B)($0.69B)($0.49B)($0.26B)($0.19B)
Operating Margin %(computed)-730.01%-639.70%
Interest Income$0.09B$0.09B$0.05B$0.01B$0.00B
Interest Expense$0.02B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($1.13B)($0.60B)($0.44B)($0.25B)($0.19B)
Income Tax Expense$0.00B($0.00B)($0.00B)($0.00B)$0.00B
Net Income($1.13B)($0.60B)($0.44B)($0.25B)($0.19B)
Net Margin %(computed)-702.95%-636.58%
Per Share & EBITDA
EPS (Basic)$-5.95$-3.58$-3.86$-3.08$-2.47
Wtd Avg Shares0.19B0.17B0.11B0.08B0.07B
EBITDA($1.09B)($0.68B)($0.48B)($0.25B)($0.18B)
EBITDA Margin %(computed)-702.72%-611.59%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Revolution Medicines, Inc.

关于Revolution Medicines, Inc.(RVMD)损益表

Revolution Medicines, Inc.(RVMD)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,RVMD实现营收$0.00B,毛利润($0.02B)(毛利率—),净利润($1.13B)(净利率—)。

常见问题

RVMD · 4 问

Revolution Medicines, Inc.(RVMD)2025财年营收为$0.00B,同比down—%。

RVMD revenueRVMD salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08